Lantern Pharma Inc
Lantern Pharma Inc logo
LTRN

Lantern Pharma Inc (LTRN)

$5.0450.7%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.8594
Day's Range
$5.0996
$4.19
52-Week Range
$8.75
1 month return12.86%
3 month return1.46%
1 year return38.77%
5 year return66.25%

Company Information

Lantern Pharma (LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. It leverages advances in machine learning, genomics, and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to its pipeline of cancer therapeutics. Lantern's focus is to improve the outcome for patients by leveraging its technology to uncover, rescue and develop abandoned or failed drugs. Its current pipeline of three drugs, with two programs in clinical stages and two in preclinical, focuses on cancers that have unique and unmet clinical needs with a clearly defined patient population. It believes that the use of machine learning, genomics and computational methods can help accelerate the revitalization, refocusing and development of small molecule-based therapies. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, this approach represents the potential to deliver best-in-class outcomes. Its team seeks out experienced industry partners, world-class scientific advisors, and innovative clinical-regulatory approaches to assist in delivering cancer therapies to patients as quickly and efficiently as possible.
OrganizationLantern Pharma Inc
Employees14
CEOMr. Panna Sharma PH.D.
IndustryCommercial Services

Analyst Recommendation

based on 2 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 2 Wall street analysts offering stock ratings for Lantern Pharma Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 382.26%

Current

$5.05

Target

$24.33

Recommendation Trend

Based on 2 analyst

Current1M Ago3M Ago
Buy
2
6
6
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
54.4M
Book Value
$5.44
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.26
Wall Street Target Price
24.33

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.94
Enterprise Value
-2363685
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.17

Technicals

Beta
0.89
50 Day MA
4.82
200 Day MA
5.61

Institutional Holdings

Vanguard Group Inc

3.38%

SMH Capital Inc.

3.37%

Goss Wealth Management LLC

1.57%

Carlson Capital LP

1.55%

Geode Capital Management, LLC

0.53%

CM Management, LLC

0.46%

Discover more

Frequently Asked Questions

What is Lantern Pharma Inc share price today?

Can Indians buy Lantern Pharma Inc shares?

How can I buy Lantern Pharma Inc shares from India?

Can Fractional shares of Lantern Pharma Inc be purchased?

What are the documents required to start investing in Lantern Pharma Inc stocks?

What are today’s High and Low prices of Lantern Pharma Inc?

What are today’s traded volumes of Lantern Pharma Inc?

What is today’s market capitalisation of Lantern Pharma Inc?

What is the 52 Week High and Low Range of Lantern Pharma Inc?

How much percentage Lantern Pharma Inc is down from its 52 Week High?

How much percentage Lantern Pharma Inc is up from its 52 Week low?

What are the historical returns of Lantern Pharma Inc?

Who is the Chief Executive Officer (CEO) of Lantern Pharma Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*